ePrivacy and GPDR Cookie Consent by TermsFeed Generator

GLYXAMBI

25MG/5MG TBL FLM 60X1

SÚKL code 0219142
Name of the product GLYXAMBI
_MA_MEDICATION_DETAIL_INFO_MED_NAME i GLYXAMBI
Supplement 25MG/5MG TBL FLM 60X1
Strenght 25MG/5MG
Pharmaceutical form Film-coated tablet
Package 60X1
Route Oral use
Wrap type
Legal status na lékařský předpis
Active substance LINAGLIPTIN (LINAGLIPTINUM)
EMPAGLIFLOZIN (EMPAGLIFLOZINUM)
ATC group A10BD19
ATC group name LINAGLIPTIN A EMPAGLIFLOZIN

Marketing authorisation information

Registration Number EU/1/16/1146/015
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder Boehringer Ingelheim International GmbH, Ingelheim am Rhein
MA Holder country NĚMECKO

Back to list